Yellow cards built into SystmOne

  • 12 November 2010

Healthcare IT supplier TPP has announced that clinicians can now report adverse drug reactions direct from its SystmOne software.

The company said its integration with the yellow card scheme run by the Medicines and Healthcare products Regulatory Authority means clinicians can now send a completed card from within SystmOne.

TPP said this means GPs will no longer need to access the MHRA website and log-in to send a yellow card.

The MHRA uses the yellow card scheme to track adverse drug reactions in the UK. It has been running for 40 years and the MHRA receives more than 20,000 reports of possible adverse drug reactions every year.

June Raine from the MHRA said: “Integration of yellow card reporting into this system will save GPs time when reporting and allows information to be quickly shared with the MHRA for effective drug safety monitoring.”

The SystmOne software will automatically ask clinicians if they want to complete a yellow card when they record a new sensitivity.

The yellow card will be populated with the name of the recently prescribed drug plus any other medications the patient is currently taking and a list of medications prescribed over the last three months.

Andrew Leece, clinical systems analyst for TPP, said the integration will save time and improve accuracy.

He added: “The integration is a vital part of the consultation process and one of many ways that SystmOne can help increase the efficiency of GP appointments.”

The yellow card functionality is available to all SystmOne users. TPP says this is the 26th partnership to take place between the company and third parties.

Subscribe To Our Newsletters

Subscribe to our newsletter

Subscribe To Our Newsletter

Related News

People want reform of AI regulation in healthcare but not overhaul

People want reform of AI regulation in healthcare but not overhaul

Concerns about safety, oversight and liability are shaping public attitudes to the regulation of AI in healthcare, according to the MHRA.
MHRA secures £3.6m to expand AI regulatory sandbox

MHRA secures £3.6m to expand AI regulatory sandbox

The Medicines and Healthcare products Regulatory Agency has secured funding to expand its AI Airlock regulatory sandbox.
UK and US strengthen partnership on MedTech regulation

UK and US strengthen partnership on MedTech regulation

The MHRA is strengthening its partnership with the US FDA to support faster access to innovative MedTech for patients in both countries.